• Tech Tech

Infants face the highest CRE infection rates among US children, with few treatment options

Symptoms may not appear until days or weeks after a child leaves the hospital.

A baby in a hospital.

Photo Credit: iStock

U.S. infants face higher rates of antibiotic-resistant CRE bacteria than older children.

The trend, identified in a Centers for Disease Control and Prevention-led analysis, is a concern for families navigating intensive care stays and complex medical conditions.

Here's what to know

A CDC-led study identified 1,845 CRE cases involving 1,753 children under age 18, according to Medical Daily. The rate of carbapenemase-producing CRE among children climbed 92% from 2019 to 2024. The findings appeared Nov. 4 in the Journal of the Pediatric Infectious Diseases Society.

Carbapenem-resistant Enterobacterales, or CRE, is a bacterial group found in the gut, including E. coli and Klebsiella. Doctors typically save carbapenem medications for serious infections because they are especially strong antibiotics, but CRE bacteria resist them. 

Some of these bacteria make enzymes called carbapenemases that block the antibiotics from working, and the genes behind those enzymes can spread from one bacterium to another.

NDM, an enzyme that makes bacteria especially hard to treat, became the most common carbapenemase type in children, surpassing KPC, after NDM-producing bacteria increased more than fourfold. The CDC-led analysis found carbapenemase-producing bacteria in about a quarter of the cases.

The overall pediatric CRE rate rose by 51% over the study's six years.

More background

Contagion Live reported that several newer antibiotic combinations effective against KPC don't block NDM. That gap makes the rise in NDM-producing bacteria especially worrying.

These bacteria spread mostly in health care settings, often from hands or equipment that aren't properly cleaned, or through devices like catheters and breathing tubes, according to Medical Daily.

CDC investigators examined medical charts for 109 children with newly identified carbapenemase-producing CRE and found that 40% were treated in intensive care, while 37% had received medical care abroad. Just 14% lacked health care risk factors.

Among the infants and toddlers reviewed, 64% had heart disease.

Children may carry the bacteria in their intestines with no outward symptoms, then go on to develop infections in the urinary tract, blood, or wounds. Symptoms may not appear until days or weeks after a child leaves the hospital.

What can be done?

For families managing catheters, feeding tubes, or central lines, hand hygiene is an important safeguard. Parents can wash their hands and ask others to do the same before touching their child.

Families can also tell new clinicians about previous resistant infections or medical care received abroad.

The study authors recommended screening children admitted after receiving care overseas. Parents can ask whether screening is appropriate, keep copies of laboratory results identifying resistant bacteria, and ask whether a pediatric infectious disease specialist should join their child's treatment team.

Hospitals can sometimes arrange these specialist consultations through telehealth.

Fever, chills, rapid breathing, unusual drowsiness, pain when urinating, or redness and drainage near a catheter insertion point or surgical wound call for prompt medical attention. Infants who develop a fever, have difficulty feeding, or show a change in color need urgent care.

Children fall outside the approved use of aztreonam-avibactam, which is approved only for patients 18 or older who have complicated intra-abdominal infections. The FDA approved the drug in February 2025; it is active against many NDM strains.

Where can I learn more?

Concerns about antibiotic resistance extend outside pediatric CRE to the environment, antibiotic use on farms, and the search for new treatments.

• As soils dry, climate change may favor more antibiotic-resistant bacteria in the environment.

• In China, a review suggests microplastics in manure may help antibiotic resistance spread.

• A startup claims an AI-designed virus treated an infection; evidence hasn't been peer-reviewed.

• The United Arab Emirates is withdrawing veterinary ciprofloxacin from the market over drug resistance concerns.

• In California, texts indicate a toddler developed E. coli requiring intensive care after drinking raw goat milk.

Get TCD's free newsletters for easy tips, smart advice, and a chance to earn $5,000 toward home upgrades. To see more stories like this one, change your Google preferences here.

Cool Divider